Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Rothwell, Alexander John. Insider active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Cumulatively, 5 filings have been recorded. History available since 15 December 2025. The latest transaction was disclosed on 15 June 2026 (50 - Grant of options). Regulator: SEDI. All data is free.
5 of 5 declarations
A declarant linked to Eupraxia Pharmaceuticals Inc. (XTSE), with the primary role listed as 5 - Senior Officer of Issuer. The total number of filings is 5, and across the sampled recent filings the modal transaction nature is 56 - Grant of rights, with dates ranging from 2025-12-19 to 2026-06-18.